Abstract
This review summarizes the most recent studies on pulmonary hypertension related to systemic sclerosis, emphasizing new insights into pathophysiology, identification of new markers, and advances in the diagnosis and treatment of this complication that greatly worsens the prognosis of patients with systemic sclerosis.
MeSH terms
-
Adult
-
Aged
-
Antihypertensive Agents / therapeutic use
-
Comorbidity
-
Drug Therapy, Combination
-
Female
-
Follow-Up Studies
-
Humans
-
Hypertension, Pulmonary / diagnosis*
-
Hypertension, Pulmonary / drug therapy
-
Hypertension, Pulmonary / epidemiology*
-
Incidence
-
Male
-
Middle Aged
-
Risk Factors
-
Scleroderma, Systemic / diagnosis*
-
Scleroderma, Systemic / drug therapy
-
Scleroderma, Systemic / epidemiology*
-
Severity of Illness Index
-
Treatment Outcome
-
Vasodilator Agents / therapeutic use
Substances
-
Antihypertensive Agents
-
Vasodilator Agents